Global Health Innovation Act of 2017
| Date | Chamber | What was voted on | Result | Yes–No | |
|---|---|---|---|---|---|
| Jan 18, 2018 | House · vote #34 | On Motion to Suspend the Rules and Pass | Passed | 423–3 | See who voted → |
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Global Health Innovation Act of 2017
This bill directs the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities.
Such reports shall include topics including: (1) USAID's health product development goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.
Became Public Law No: 115-411.
- Engrossed in House Formatted Text PDF Formatted XML
- Enrolled Bill Formatted Text PDF Formatted XML
- Introduced in House Formatted Text PDF Formatted XML
- Public Law Formatted Text PDF United States Legislative Markup
- Referred in Senate Formatted Text PDF Formatted XML
- Reported to Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 1660: Global Health Innovation Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-1660/
"H.R. 1660: Global Health Innovation Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-1660/.
H.R. 1660, 115th Cong. (2026), https://openamerica.io/bill/115-HR-1660/.
[H.R. 1660: Global Health Innovation Act of 2017](https://openamerica.io/bill/115-HR-1660/)